Day: 15 August 2026

Mounjaro and lipoedema-More Than a Weight-Loss Drug?

Mounjaro has become widely known as a weight-loss drug but research into tirzepatide, its active ingredient, now extends well beyond its use in weight reduction. Lipoedema is also more complex than excess fat deposition. Current research describes changes involving adipose tissue function, inflammation, fibrosis and the extracellular matrix, alongside vascular, hormonal and metabolic changes. Mitochondrial […]